Functional Outcomes and Physical Impairments in Pediatric Critical Care Survivors: A Scoping Review

Chengsi Ong1, Jan Hau Lee, Melvin K S Leow

  • 11Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 2Department of Nutrition and Dietetics, KK Women's and Children's Hospital, Singapore, Singapore. 3Children's Intensive Care Unit, KK Women's and Children's Hospital, Singapore, Singapore. 4Office of Clinical Sciences, Duke-NUS School of Medicine, Singapore, Singapore. 5Clinical Nutrition Research Centre, A*STAR-NUHS, Centre for Translational Medicine, Singapore, Singapore. 6Department of Endocrinology, Tan Tock Seng Hospital, Singapore, Singapore. 7Centre for Human Health and Performance, University College London, London, United Kingdom. 8Institute of Sport, Exercise and Health, University College Hospitals London, London, United Kingdom. 9Division of Critical Care, University College Hospitals London, London, United Kingdom. 10Division of Respiratory and Critical Care, National University Hospital, Singapore, Singapore.

Insights

Pediatric critical care survivors often face long-term physical impairments, with rates varying by measurement timing and tools. Further research is needed to understand these functional outcomes.

Area of Science:

  • Pediatric critical care
  • Rehabilitation medicine
  • Functional outcomes

Background:

  • Increasing survival rates in pediatric critical illness necessitate understanding long-term physical sequelae.
  • Limited knowledge exists regarding the prevalence and nature of physical impairments in these survivors.

Purpose of the Study:

  • To critically appraise literature on functional outcome measurement tools.
  • To determine the prevalence of physical impairments in pediatric critical care survivors.
  • To identify risk factors associated with these impairments.

Main Methods:

  • Scoping review of literature.
  • Searched PubMed, Embase, and CINAHL databases.
  • Included studies on children (0-18 years) admitted to the pediatric intensive care unit (PICU).

Main Results:

  • Utilized three global assessment tools and eight multidimensional measures.
  • Reported functional impairment rates from 10% to 36% at discharge and 10% to 13% long-term.
  • Identified illness severity, organ dysfunction, ICU stay length, and younger age as risk factors.

Conclusions:

  • Physical impairments can be persistent in pediatric critical care survivors.
  • Variability in measurement tools and timing limits generalizability.
  • Standardized, multi-time-point measures are crucial for comprehensive assessment.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
322
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
858
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
443
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
699
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K